Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Retention in treatment | |||||
[42]
Systematic review |
203 people 2 RCTs in this analysis |
Proportion of people retained in treatment
26/50 (52%) with naltrexone 15/33 (45%) with placebo |
RR 1.18 95% CI 0.72 to 1.91 P = 0.51 |
Not significant | |
[43]
Systematic review |
40 people Data from 1 RCT |
Proportion of people retained in treatment
15/22 (68%) with high-dose naltrexone 7/18 (39%) with placebo |
RR 1.75 95% CI 0.92 to 3.34 P = 0.88 |
Not significant | |
[43]
Systematic review |
38 people Data from 1 RCT |
Proportion of people retained in treatment
12/20 (60%) with low-dose naltrexone 7/18 (39%) with placebo |
RR 1.54 95% CI 0.78 to 3.05 |
Not significant |